electroCore Has A Line Of Sight At Cash Breakeven
electroCore, Inc. ECOR
$10.88
▼ -1.36%
($-0.15)
🎈 Low Float
Open
$11.16
Prev Close
$11.03
Day Range
$10.52 – $11.33
52W Range
$4.41 – $12.70
Market Cap
$98.09M
Beta
1.19
EPS (TTM)
$-1.66
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2018-06-22 |
| Shares Out. | 9,020,000 |
| Website | electrocore.com/ ↗ |
| Phone | 18009279800 |
| Employees | 83 |
| Revenue | $9.5M |
| Gross Profit | $8.2M |
| Net Income | -$3.1M |
| Free Cash Flow | -$9.7M |
| Total Assets | $17.1M |
| Total Liabilities | $19.9M |
| Equity | -$2.8M |
About electroCore, Inc.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
electroCore, Inc. is a publicly traded company under the ticker symbol ECOR on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.